国邦医药 (605507)
Guobang Pharma Ltd.
K-Line Chart
No K-line data available
Company NameGuobang Pharmaceutical Group Co., Ltd.
Listing Date2021-08-02
Issue Price32.57RMB
Registered Capital55882.3510k RMB
Legal RepresentativeQiu Jiajun
Registered AddressNo. 60 Xingmei Avenue, Xinchang Provincial High-Tech Industrial Park, Zhejiang Province
IndustryChemical Pharmaceuticals
Main BusinessMainly engaged in the research and development, production, and sales of related products in the pharmaceutical and animal health sectors.
Company ProfileGuobang Pharmaceutical Group Co., Ltd. was founded in 1996. It is a global, multi-variety pharmaceutical manufacturing company with advantages in the industrial chain and a complete set of industrial platform elements, serving as a key participant in the global chemical pharmaceutical manufacturing supply chain. The company is primarily engaged in the R&D, production, and sales of related products in the pharmaceutical and animal health sectors. Its pharmaceutical segment covers active pharmaceutical ingredients (APIs), key pharmaceutical intermediates, and finished dosage forms, while its animal health segment covers veterinary APIs, veterinary additives, and finished dosage forms.
Guobang Pharmaceutical's production bases are located in the Zhejiang Xinchang Provincial High-Tech Industrial Development Zone, the Zhejiang Hangzhou Bay Shangyu National Economic and Technological Development Zone, and the Shandong Weifang National Binhai Economic and Technological Development Zone. The Group employs over 2,700 people, and its products are sold in more than 110 countries and regions worldwide, covering a population of over 6.5 billion. Several of its product varieties rank first globally in terms of production and sales volume.
Guobang Pharmaceutical adheres to the corporate philosophy of 'Building People, Building the Nation; Developing Industry, Revitalizing the Country.' It pursues the work goal of 'Two Leaderships,' follows the corporate development culture of 'Putting Strivers First, Partnering with Elites, and Sharing Benefits with All Employees,' advocates the corporate spirit of 'Professionalism, Harmony, and Striving,' and follows a resource-saving and environmentally friendly development path, contributing to the health industry for both humans and animals.
Stock Details
1. Key Indicators
- Total Shares(W): 55882.35
- Circulating A-Shares(W): 30172.22
- Earnings Per Share(RMB): 1.2100
- Net Assets Per Share(RMB): 14.8019
- Operating Revenue(W RMB): 446988.44
- Total Profit(W RMB): 77487.77
- **Net Profit Attributable to Parent(W RMB) **: 67024.26
- Net Profit Growth Rate(%): 15.78
- Weighted Return on Equity(%): 8.2400
- Operating Cash Flow Per Share(RMB): 0.7260
- Undistributed Profit Per Share(RMB): 7.1642
- Capital Reserve Per Share(RMB): 6.4558
2. Main Business
The main business covers:
- Research, development, production, and sales of related products in the pharmaceutical and animal health sectors.
3. Company Basic Information
- Company Name: Guobang Pharmaceutical Group Co., Ltd.
- Listing Date: 2021-08-02
- Industry: Pharmaceutical Manufacturing
- Address: No. 60 Xingmei Avenue, Xinchang Provincial High-tech Industrial Park, Zhejiang Province
- Website: www.gbgcn.com
- Company Profile: The company was established through the overall transformation and restructuring of Guobang Co., Ltd.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang State-owned Capital Operation Co., Ltd. | General Legal Person | 3830.63 | 12.70 |
| 2 | Weifang Shiqi Hui Equity Investment Partnership (Limited Partnership) | General Legal Person | 2257.56 | 7.48 |
| 3 | Shaoxing Jinze Enterprise Management Co., Ltd. | General Legal Person | 687.50 | 2.28 |
| 4 | Shaoxing Shangyu State-owned Capital Investment Operation Co., Ltd. | General Legal Person | 687.50 | 2.28 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 551.35 | 1.83 |
| 6 | Runtu Jinheng (Jiaxing) Investment Partnership (Limited Partnership) | General Legal Person | 528.52 | 1.75 |
| 7 | Weifang Hongde Hui Equity Investment Partnership (Limited Partnership) | General Legal Person | 444.16 | 1.47 |
| 8 | Haoyu Asset Management (Beijing) Co., Ltd. - Nanjing Haoyu Hongmeng Equity Investment Partnership (Limited Partnership) | Asset Management Plan | 387.34 | 1.28 |
| 9 | Penghua Quality Governance Hybrid Securities Investment Fund (LOF) Class A | Fund | 224.09 | 0.74 |
| 10 | Penghua Industry Selection Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 116.53 | 0.39 |
5. Concept Sectors
- Helicobacter Pylori
- Synthetic Biology
- Pet Economy
- High-performing Stocks
- Share Buyback Plan
- Employee Stock Ownership
- Equity Transfer
- Below IPO Price
- Tencent Ji'an
- SSE 580
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information